Related Experiment Video
Updated: Jun 1, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Management of chronic hepatitis B
Hatef Massoumi1, Paul Martin, Hui-Hui Tan
1Division of Gastroenterology and Hepatology, Albert Einstein College of Medicine, Bronx, New York, USA.
Insights
Chronic hepatitis B is a significant global health issue. Treatment aims to prevent severe liver disease, cancer, and death, with timely referral for transplant evaluation crucial for advanced cases.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Chronic hepatitis B (CHB) represents a substantial global health burden, impacting healthcare resources and finances.
- CHB infection can lead to severe liver conditions, including cirrhosis and hepatocellular carcinoma.
- Disease progression is influenced by host and viral factors, necessitating individualized treatment strategies.
Purpose of the Study:
- To summarize the current understanding of chronic hepatitis B.
- To outline the goals of hepatitis B treatment.
- To emphasize the importance of timely management for patients with advanced disease.
Main Methods:
- Review of existing literature on chronic hepatitis B natural history and treatment.
- Analysis of factors influencing disease progression and treatment outcomes.
- Guidelines for patient management, including referral criteria.
Main Results:
- The natural history of chronic hepatitis B varies based on acquisition timing and host/viral factors.
- Current treatments aim to halt disease progression, prevent complications like liver failure and cancer, and reduce mortality.
- Early identification and management are key to improving patient outcomes.
Conclusions:
- Effective management of chronic hepatitis B is essential to mitigate its global health impact.
- Treatment goals focus on preventing long-term complications and improving survival.
- Patients with decompensated cirrhosis require prompt referral to specialized liver transplant centers.
Abstract:
Chronic hepatitis B continues to be a major global health burden. It accounts for a substantial impact on health care resources and finances in many parts of the world including Europe. Natural history and disease spectrum are varied, depending on when and how the infection is acquired. The chronic infective state increases patients' risk of progression to liver cirrhosis or hepatocellular carcinoma. Several treatment options are currently available, but their use depends on the stage of the patient's infection, which is influenced by both host and viral factors. The ultimate goals in hepatitis B treatment are to prevent disease progression, hepatic decompensation, hepatocellular carcinoma, and death. Patients with decompensated liver cirrhosis should be referred to specialized transplant centers in a timely manner.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Hepatitis
Chronic Pancreatitis II: Collaborative Care
Assessment:
Viral Hepatitis I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test